Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.26 USD
Change Today +0.82 / 5.68%
Volume 95.2K
NSTG On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

nanostring technologies inc (NSTG) Snapshot

Open
$14.28
Previous Close
$14.44
Day High
$15.38
Day Low
$14.28
52 Week High
07/16/15 - $17.62
52 Week Low
10/13/14 - $7.80
Market Cap
295.8M
Average Volume 10 Days
107.4K
EPS TTM
$-2.93
Shares Outstanding
19.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NANOSTRING TECHNOLOGIES INC (NSTG)

Related News

No related news articles were found.

nanostring technologies inc (NSTG) Related Businessweek News

No Related Businessweek News Found

nanostring technologies inc (NSTG) Details

NanoString Technologies, Inc. develops, manufacture, and sells products that unlock scientifically valuable and clinically actionable genomic information from minute amounts of tissue. The company provides nCounter Analysis System, an automated, multi-application, digital detection, and counting system that includes nCounter Prep Station, an automated liquid handling component for processing and preparing the samples for data collection; and nCounter Digital Analyzer, which collects data from samples through the images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nSolver Analysis software, a data analysis program that offers researchers the ability to quality check, normalize, and analyze their data. In addition, it provides Pan Cancer pathways gene expression panels, PanCancer immune profiling gene expression panels, gene expression panels, miRNA expression panels, and cancer copy number variation panels; custom CodeSets; and master kits that include ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer. It markets its systems and related consumables to researchers in academic, government, and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, as well as to clinical laboratories and medical centers for diagnostic use in North America, Europe, the Middle East, and the Asia Pacific. The company was founded in 2003 and is headquartered in Seattle, Washington.

276 Employees
Last Reported Date: 03/13/15
Founded in 2003

nanostring technologies inc (NSTG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $441.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $349.2K
Senior Vice President of Operations & Adminis...
Total Annual Compensation: $325.0K
Senior Vice President of Research & Developme...
Total Annual Compensation: $293.7K
Compensation as of Fiscal Year 2014.

nanostring technologies inc (NSTG) Key Developments

NanoString Technologies, Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Year 2015

NanoString Technologies, Inc. reported consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenue of $13,066,000 compared to $10,881,000 a year ago. Loss from operations was $11,426,000 compared to $12,133,000 a year ago. Net loss attributable to the common stockholders was $12,404,000 or $0.66 per basic and diluted share compared to $14,088,000 or $0.78 per basic and diluted share a year ago. For the six months period, the company reported total revenue of $24,659,000 compared to $19,632,000 a year ago. Loss from operations was $25,214,000 compared to $23,113,000 a year ago. Net loss attributable to the common stockholders was $27,298,000 or $1.47 per basic and diluted share compared to $25,510,000 or $1.46 per basic and diluted share a year ago. The company provided earnings guidance for the year 2015. For the year, the company expects total revenue in the range of $60 million to $63 million, compared to the previous range of $58 million to $61 million. Operating loss in the range of $41 million to $47 million, compared to the previous range of $43 million to $49 million.

NanoString Technologies, Inc. to Report Q2, 2015 Results on Aug 04, 2015

NanoString Technologies, Inc. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Aug 04, 2015

NanoString Technologies, Inc., Q2 2015 Earnings Call, Aug 04, 2015

NanoString Technologies, Inc., Q2 2015 Earnings Call, Aug 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NSTG:US $15.26 USD +0.82

NSTG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $2.87 USD +0.03
Exiqon A/S kr11.80 DKK +0.10
Fluidigm Corp $11.70 USD +0.32
Pacific Biosciences of California Inc $5.07 USD +0.21
Sequenom Inc $2.23 USD +0.09
View Industry Companies
 

Industry Analysis

NSTG

Industry Average

Valuation NSTG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.5x
Price/Book 8.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOSTRING TECHNOLOGIES INC, please visit www.nanostring.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.